ESC 365 - Defibrillation testing at implant of subcutaneous implantable cardioverter defibrillator: weighting propensity score analysis and results from nationwide HONEST cohort

EHRA Premium Access

Defibrillation testing at implant of subcutaneous implantable cardioverter defibrillator: weighting propensity score analysis and results from nationwide HONEST cohort

Session: Device therapy (2)

Topic: Cardioversion and Defibrillation

Speaker: Doctor F. kerkouri (Brest, FR)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Fawzi kerkouri

University Hospital of Brest, Brest (France)

0 follower

6 more presentations in this session

Subcutaneous implantable cardioverter defibrillator in pediatric and young adults: an analysis from the European SIDECAR Registry

Speaker: Doctor M. Silvetti (Rome, IT)

Bidirectional interaction between implantable cardioverter-defibrillator therapy and mental disorders: nationwide cohort study

Speaker: Doctor J. Kim (Seoul, KR)

Deprivation and device therapy: understanding the impact of socioeconomic status on ICD therapy outcomes

Speaker: Mr C. Monkhouse (London, GB)

Predictors of syncope recurrence in reflex syncope patients with dual-chamber pacemakers with anti-reflex functionality

Speaker: Doctor T. Vo (Ho Chi Minh, VN)

Implantable cardioverter defibrillator resistant mortality in ischemic and dilated cardiomyopathy across therapeutic eras: a single, tertiary center experience

Speaker: Doctor M. Blondeel (Leuven, BE)

Access the full session

Device therapy (2)

Speakers: Doctor F. kerkouri, Doctor M. Silvetti, Doctor J. Kim, Mr C. Monkhouse, Doctor T. Vo...

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources